Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol opti system

Vox Sanguinis

Volumn 73, Issue 4, 1997, Pages 212-219

  Högman, Claes F ^a   Eriksson, L ^b   Wallvik, J ^b   Payrat, J M ^b  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIPHOSPHOGLYCERIC ACID; CITRIC ACID; ERYTHRO SOL; PRESERVATIVE; THROMBOCYTE CONCENTRATE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CELL COUNT; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE PRESERVATION; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; OXYGEN AFFINITY; PRIORITY JOURNAL; THROMBOCYTE PRESERVATION; THROMBOCYTOPENIA;

EID: 1842339863     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.7340212.x     Document Type: Article

References (29)

1. Valtis DJ, Kennedy AC: Defective gas-transport function of stored red blood cells. Lancet 1954;1:119-125.
2. Duhm J, Gerlach E: Metabolism and function of 2,3-diphosphoglycerate in red blood cells; in Greenwalt TJ, Jamieson GA (eds): The Human Red Cell in Vitro. New York, London, 1974. pp 111-148.
3. Chanutin A, Curnish RR: Effect of organic and inorganic phosphates on the oxygen equilibrium of human erythrocytes. Arch Biochem 1967;121:96-102.
4. Benesch R, Benesch RE, Yu CI: Reciprocal binding of oxygen and diphosphoglycerate by human hemoglobin. Proc Nat Acad Sci USA 1968;59:526-532.
5. Collins JA: Abnormal hemoglobin-oxygen affinity and surgical hemotherapy; in Collins JA, Lundsgaard-Hansen P (eds): Surgical Hemotherapy. Bibl Haematol. Basel, Karger, 1980, vol 46, pp 59-69.
6. Heaton WAL, Keegan T, Holme S: In vivo regeneration of red cell 2,3-diphosphoglycerate following transfusion of DPG-depleted AS-1, AS-3 and CPDA-1 red cells. Br J Haematol 1989;71:131-136.
7. Woodson RD: Importance of 2,3-DPG in banked blood: New data in animal models. Prog Clin Biol Res 1982;108:69-78.
8. Kimura H, Hamasaki N, Yamamoto M, Tomonaga M: Circulation of red blood cells having high levels of 2,3-bisphosphoglycerate protects rat brain from ischemic metabolic changes during hemodilution. Stroke 1995;26:1431-1437.
9. Högman CF, Eriksson L, Gong J, Vikholm K, Debrauwere J, Payrat JM: Half-strength citrate CPD and new additive solutions for improved blood preservation. 2. The effect of storage at ambient temperature before component preparation and different means of supplying glucose to the red cells. Transfus Med 1993;3:211-222.
10. Prowse C, Waterston YG, Dawes J, Farrugia A: Studies of the procurement of blood coagulation factor VIII: In vitro studies on blood components prepared in half-strength anticoagulant. Vox Sang 1987;52:257-264.
11. Högman CF, Eriksson L, Gong J, Payrat JM, Debrauwere J: Half-strength citrate CPD and new additive solutions for improved blood preservation. 1. Studies of six experimental solutions. Transfus Med 1993;3:43-50.
12. Högman CF, Eriksson L, Gong J, Högman AB, Vikholm K., Debrauwere J, Payrat JM, Stewart M: Half-strength citrate CPD combined with a new additive solution for improved storage of red blood cells suitable for clinical use. Vox Sang 1993;65:271-278.
13. Suontaka AM, Akerblom O, Blombäck M, Eriksson L, Högman CF, Payrat JM: Stability of blood coagulation factors and inhibitors in blood drawn into half-strength citrate anticoagulant. Vox Sang 1996;71:97-102.
14. Solheim BJ, Brosstad F, Högman CF: Improved blood preservation with 0.5CPD-Erythrosol. Vox Sang 1996;70(suppl 2):143.
15. Tuuk Adriani WPA, Smit Sibinga CTh: Erythrosol, a new preservation solution for erythrocytes. Vox Sang 1996;70(suppl 2):143.
16. Farrugia A, Douglas C, James J, Whyte G: Red cell and platelet concentrates from blood collected into half-strength citrate anticoagulant: Improved maintenance of red cell 2,3-diphosphoglycerate in half citrate red cells. Vox Sang 1992;63:31-38.
17. Gulliksson H, Eriksson L, Högman CF, Payrat M: Buffy-coat-derived platelet concentrates prepared from half-strength citrate CPD and CPD whole blood units. Comparison between three additive solutions: In vitro studies. Vox Sang 1995;68:152-159.
18. Högman CF, Eriksson L, Hedlund K, Wallvik J: The bottom and top system: A new technique for blood component preparation and storage. Vox Sang 1988;55:211-217.
19. Moroff G, Sohmer PR, Button LN, and members of the ad hoc Committee. Proposed standardization of methods for determining the 24hour survival of stored red cells. Transfusion 1984;24:109-114.
20. Mollison PL, Engelfriet CP, Contreras M: Blood Transfusion in Clinical Medicine, ed 9. Oxford, Black well, 1993.
21. Högman CF, Eriksson L, Ericson A, Reppucci AJ: Storage of salinc-adenine-glucose-mannitol-suspended red cells in a new plastic container: Polyvinylchloride plasticized with butyryln-trihexyl-citrate. Transfusion 1991;31:26-29.
22. Lindc T, Sandhagen B, Bratteby LE, de Verdier CH. Danielsson BG, Wikström B: Reduced oxygen affinity contributes to improved releasing capacity during erythropoictin treatment of renal anaemia. Nephrol Dial Transplant 1993;8:524-529.
23. Eriksson L, Högman CF: Platelet concentrates in an additive solution prepared from pooled bufry coats. 1. In vitro studies. Vox Sang 1990;59:140-145.
24. Pietersz RNI, de Korte D, Reesink H W, Dekker WIA, van den Ende A, Loos JA: Storage of whole blood for up to 24 hours at ambient temperature prior to component preparation. Vox Sang 1989;56:145-150.
25. Moroff G, Holme S, Heaton WAL, Kevy S, Jacobson M, Popovsky M: Effect of an 8-hour holding period on in vivo and in vitro properties of red cells and factor VIII content of plasma after collection in a red cell additive system. Transfusion 1990;30:828-832.
26. Kristensen J, Eriksson L, Olsson K, Killander A, Högman CF: Functional capacity of transfused platelets estimated by the Thrombostat 4000/2. Eur J Haematol 1993;51:152-155.
27. Eriksson L, Kristensen J, Olsson K, Bring J, Högman CF: Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Vox Sang 1996;70:69-75.
28. Strindberg J, Berlin G: Transfusion of platelet concentrates - Clinical evaluation of two preparations. Eur J Haematol 1996;57:307-311.
29. Högman CF, Berséus O, Eriksson L, Gulliksson H: Buffy-coat derived platelet concentrates: Swedish experience. Transfus Sci, in press.